Wall Street Rebounds, Eli Lilly Rallies, UnitedHealth Group Plummets: What's Driving Markets Thursday?
1. Eli Lilly's Orforglipron achieved successful Phase 3 trial results. 2. LLY shares surged 16% following the announcement. 3. Positive market sentiment is rising amidst ongoing trade negotiations. 4. Health Care Select Sector SPDR Fund slightly lagged market performance. 5. UnitedHealth's decline may influence sentiment towards health care stocks.